Highlights Teva Pharmaceutical Industries Limited

Equities

TEVA

US8816242098

Market Closed - Nyse Other stock markets 16:00:02 2024-05-08 EDT			5-day change	1st Jan Change
15.74 ^USD	+12.83%		+12.59%	+50.77%

05-08	Sector Update: Health Care Stocks Slipping Wednesday Afternoon	MT
05-08	Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Slipping Wednesday Afternoon	05-08	MT
Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed	05-08	MT
Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday	05-08	MT
Sector Update: Health Care	05-08	MT
Teva Pharmaceutical Industries Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed	05-08	MT
Earnings Flash (TEVA) TEVA PHARMACEUTICAL INDUSTRIES LIMITED Posts Q1 Revenue $3.82B	05-08	MT
Earnings Flash (TEVA) TEVA PHARMACEUTICAL INDUSTRIES LIMITED Posts Q1 EPS $0.48	05-08	MT
Teva Pharm Q1 profit falls short of estimates, revenue gains	05-08	RE
Teva Pharmaceutical Industries Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
Teva Pharmaceutical Industries Limited Reaffirms Earnings Guidance for the Full Year 2024	05-08	CI
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	04-30	MT
Top Midday Stories: Shares of Eli Lilly, HSBC Get Post-Earnings Bump; BBVA Exploring Merger With Sabadell; FTC Disputes 300 'Junk' Patent Listings	04-30	MT
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	04-30	MT
Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals	04-30	MT
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	04-30	MT
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	04-30	MT
Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent	04-30	MT
Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court	04-22	MT
Alvotech Shares Rise After Signing Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US	04-19	MT
Alvotech Signs Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US	04-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Teva Pharmaceutical Industries isn't out of the woods yet

February 01, 2024 at 04:41 am

INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised

August 02, 2023 at 03:19 pm